LeMaitre Vascular Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 35/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 104.33.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LeMaitre Vascular Inc's Score
Industry at a Glance
Industry Ranking
35 / 208
Overall Ranking
110 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
104.333
Target Price
+25.81%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
LeMaitre Vascular Inc Highlights
StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.01% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 219.86M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 35.99, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.34M shares, decreasing 5.36% quarter-over-quarter.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOLemaitre (George W)
Websitehttps://www.lemaitre.com/
FAQs
What is the current price of LeMaitre Vascular Inc (LMAT)?
The current price of LeMaitre Vascular Inc (LMAT) is 84.510.
What is the symbol of LeMaitre Vascular Inc?
The ticker symbol of LeMaitre Vascular Inc is LMAT.
What is the 52-week high of LeMaitre Vascular Inc?
The 52-week high of LeMaitre Vascular Inc is 105.550.
What is the 52-week low of LeMaitre Vascular Inc?
The 52-week low of LeMaitre Vascular Inc is 71.420.
What is the market capitalization of LeMaitre Vascular Inc?
The market capitalization of LeMaitre Vascular Inc is 1.92B.
What is the net income of LeMaitre Vascular Inc?
The net income of LeMaitre Vascular Inc is 44.04M.
Is LeMaitre Vascular Inc (LMAT) currently rated as Buy, Hold, or Sell?
According to analysts, LeMaitre Vascular Inc (LMAT) has an overall rating of Buy, with a price target of 104.333.
What is the Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT)?
The Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT) is 2.361.